Practice
Featured experience
PSG VI $6 billion fundraise and $2 billion continuation fund
We advised PSG on the fundraise for PSG VI and a multi-asset GP-led secondary continuation fund transaction
J.F. Lehman closes $2.2 billion Fund VI
We advised J.F. Lehman on the fundraise and related matters
GHK Capital Partners completes $870 million fundraise for its second fund
We advised GHK Capital Partners on the fundraise and related matters for GHK Fund II
Grayscale Bitcoin Trust approved as world’s largest bitcoin ETF
We advised Grayscale in the yearslong effort to secure SEC approval for the NYSE Arca listing
Marsh McLennan $1 billion senior notes offering
We advised Marsh McLennan on its investment-grade notes offering
Immatics $110 million follow-on offering
We advised Immatics on the offering of shares
Iris Energy $100 million equity line financing
We advised Iris Energy on the transaction
Roivant Sciences $400 million at-the-market offering
We advised the company on an SEC-registered at-the-market offering
Interra Acquisition HK$1 billion IPO
We advised the SPAC on its IPO and HKEX listing
BBVA $1.75 billion senior non-preferred notes offering
We advised BBVA on its offering of senior non-preferred fixed-to-fixed-rate notes
Mitsubishi HC Capital $500 million senior notes offering
We advised Mitsubishi HC Capital on its senior notes offering
Biocytogen HK$549 million IPO
We advised Biocytogen on its IPO and HKEX listing
Banco Santander $3.5 billion senior non-preferred notes offering
We advised Banco Santander on its offering of fixed-rate notes
Morgan Stanley $1 billion preferred stock offering
We advised Morgan Stanley on its SEC-registered offering